G2A, a G protein-coupled receptor for which lysophosphatidylcholine (LPC) is a high affinity ligand, belongs to a newly defined lysophospholipid receptor subfamily. Expression of G2A is transcriptionally upregulated by stress-inducing and cell-damaging agents, and ectopic expression of G2A leads to growth inhibition. However, the G proteins that functionally couple to G2A have not been elucidated in detail. We report here that G2A ligand-independently stimulates the accumulation of both inositol phosphates (InsP) and cAMP. LPC does not further enhance InsP accumulation but dose-dependently augments intracellular cAMP concentration.
Functionality of AU5-G2A was comparable to that of wild type G2A in apoptosis assays, second messenger accumulation, and NF-κB activation. The G2A-GFP fusion construct was prepared as described in Weng et al. (1) .
Cell culture, transfection, and luciferase assay. HeLa cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2mM L-glutamine, 100 IU/mL penicillin, and 50 µg/mL streptomycin. Cells were transfected at 40-80% confluence in 6-well plates using LipofectAMINE Plus reagent (Invitrogen, Carlsbad, CA) as previously described (12) . Cells were transfected with pRK5, G2A
and/or other constructs of interest and with 0.2 µg of the 3x NF-κB-luciferase reporter construct and 0.02 µg of pCMVβ (β-galactosidase expression vector) for normalization of transfection efficiency. Total DNA was made equivalent between samples by adding empty vector (pRK5).
Twenty-four hours post-transfection, cells were starved for 16-18 hours in serum-free DMEM, and treated with ligand for 4 hours if necessary. Cells were then washed twice with 1x phosphate-buffered saline (PBS), lysed with 1X Reporter Lysis Buffer (Promega), and supernatant collected. Luciferase substrate (Promega) and β-galactosidase substrate were added to two different aliquots of supernatant and luminescence measured with a Femtomaster FB12 luminometer (Berthold Detection Systems; Pforzheim, Germany). Luciferase activities were normalized against β-galactosidase. Normalized data for all samples were plotted using Prism software (Version 3.0, GraphPad, San Diego, CA).
RT-PCR and detection of cell surface expression.
To confirm expression of G2A in transiently transfected HeLa cells or primary lymphocytes by RT-PCR, first-strand cDNA was synthesized with 2 µg of total RNA isolated using the Trizol reagent and the Superscript II preamplification system (Invitrogen). Fifteen percent of the first strand cDNA synthesis product was then used for PCR with the primers XGR3 (5'-CTCGTCGGGATCGTTCACTAC-3') and HG2AC1 as described previously (1) . GPR4 expression in primary cells was detected using the by guest on August 17, 2017 http://www.jbc.org/ Downloaded from 8 using a competitive enzyme immunoassay (Biomol, Plymouth Meeting, PA). Twenty-four hours after transfection, the medium was replaced with DMEM supplemented with 0.1% FBS, and cAMP production accumulated in the presence of DMEM supplemented with 0.5 mM isobutylmethylxanthine (IBMX), +/-LPC for 45 min at 37°C. Alternatively, cells were pre-treated with PTX (500 ng/mL) or 100 µM 2',5'-dideoxyadenosine (DDA) for 4 hrs before ligand stimulation. The medium was then removed and replaced with 0.1 M HCl. After the specified incubation times, p-nitrophenyl phosphate substrate was added, the reaction stopped, and OD determined using a microplate reader at 405 nm. Standard cAMP curves and calculations were performed according to the manufacturer's instructions. All cells were co-transfected with pCMVβ and all data were normalized against β-galactosidase to account for variances in transfection efficiency.
Isolation of primary lymphocytes. Anti-coagulated whole blood from human donors was then lysed for cAMP analysis, or incubated for 14-16 hrs, stained with TMRE and analyzed by flow cytometry. In the latter case, lymphocytes were kept in RPMI medium containing 5% of donor serum which was collected from the upper phase after gradient centrifugation of diluted whole blood.
Results
Ligand-independent coupling of G2A to Gα α q. G2A is a transcriptionally regulated, stress-inducible GPCR that has been shown to ligand-independently couple to Gα13 in the activation of RhoA (6, 9) . We examined whether G2A also activates other Gα proteins since Gα13-coupling GPCRs are often found to interact with more than one G protein. Upon GPCR activation, certain Gα subunits (e.g. Gαq) and βγ subunits activate phospholipase-Cβ (PLCβ) which cleaves phosphoinositol diphosphate (PIP 2 ) into two products, diacylglycerol and inositol triphosphate. Thus, the accumulation of inositol phosphates (InsP) is a useful and effective indication of GPCR-mediated PLCβ activation. G2A was exogenously expressed in HeLa cells, a human carcinoma cell line devoid of endogenous G2A. Expression of G2A was confirmed by RT-PCR and cell surface expression of the receptor was observed by flow cytometric analysis using a monoclonal antibody against an AU5 tag that was fused to the N-terminus of G2A.
Approximately 30% of transfected cells showed a high level of cell surface receptor expression 24 hours after transfection (data not shown). Expression of G2A resulted in a 3.5-fold increase of InsP accumulation, as compared to mock-transfected cells (Fig. 1A) . Stimulation of transfected cells with the G2A agonist LPC did not further increase InsP accumulation.
Pertussis toxin (PTX), which ADP-ribosylates Gαi/Gαo and prevents functional coupling to their respective GPCRs, did not inhibit G2A-mediated increase in InsP accumulation. To determine the role of Gβγ in this response, HeLa cells were transfected with an expression construct containing the carboxyl terminus fragment of βARK (βARKct), a known βγ scavenger (13) . It was found that βARKct did not inhibit G2A-mediated InsP accumulation (Fig. 1B) . These results suggest that G2A activates a Gα protein, most likely Gαq, regardless of LPC stimulation. As a positive control, expression of a constitutively active Gαq (Q209L) led to a ~3-fold induction of InsP accumulation (data not shown).
It was recently reported that certain Gα proteins, including Gαq and Gα13, are involved in GPCR-mediated activation of nuclear factor κB (NF-κB) (12, (14) (15) (16) . We used this property of G proteins to further confirm functional coupling of G2A to these two G proteins. HeLa cells were co-transfected with expression constructs for a NF-κB luciferase reporter and G2A, and in some samples, one of the Gα proteins. As shown in Fig. 2A , expression of G2A resulted in a potent induction of NF-κB-mediated transcription characterized by an increase in luciferase activity. Co-expression of Gαq was found to augment G2A-induced luciferase activity by approximately 90%, whereas co-expression of Gα13, known to couple to G2A (6, 9) , also potentiated luciferase reporter activity. Neither of these Gα proteins was able to induce the expression of NF-κB-driven luciferase activity when expressed alone, indicating that the observed enhancement results from specific functional coupling with G2A. Consistent with the ligand-independent nature of these coupling events, LPC stimulation did not further increase G2A-induced NF-κB-luciferase activity (data not shown).
We also employed a loss-of-function approach that utilizes RGS constructs to block specific G protein pathways (17, 18) . P115RhoGEF, an effector which couples Gα13 to the activation of RhoA, contains an N-terminal RGS domain that serves to down-regulate the Gα13 signal (19) . GRK2 contains an N-terminal RGS domain that binds to and specifically inhibits Gαq signaling (20) . The two RGS truncation constructs shown in Fig. 2B were used to downregulate signaling by Gα13 and Gαq, respectively. Our results show that either GRK2RGS or p115RGS alone inhibited G2A-induced NF-κB activation by 50% and 36%, respectively ( by approximately 30%. Based on these observations, it appears that G2A couples to Gαs, and possibly Gαi, in the absence of LPC stimulation, in that the ligand-independent increase in cAMP is slightly enhanced by abrogating the inhibitory effect of Gαi with PTX pre-treatment.
The inhibitory activity by Gαi appears to be relatively weak, as LPC stimulation further increased cAMP levels indicating that G2A-mediated activation of Gαs offsets the inhibition by Gαi.
To examine the dose effect of LPC on G2A-mediated cAMP elevation, we treated both mock-transfected and G2A-transfected cells with increasing concentrations of LPC (Fig. 3B ).
Indeed, there exists a correlation between LPC dose and G2A-mediated cAMP elevation, with a maximum response at 0.5 µM LPC. At ≥ 10 µM LPC, there was no further increase in cAMP.
This may be due to non-specific effects or decreasing activity of LPC at concentrations ≥ 10 µM
(5).
Expression of G2A causes apoptosis. Evidence exists that expression of G2A is induced by various DNA-damaging agents such as chemotherapeutics, UV, and X-ray.
Furthermore, it is known that expression of G2A causes NIH 3T3 cells to accumulate at G2/M in the cell cycle and that it inhibits transformation of cells by the oncogene BCR-ABL (1). These findings suggest a potential link between G2A expression and suppression of cell growth, and prompted us to examine whether G2A also induces apoptosis. HeLa cells were transfected to express G2A as described above. Twenty-four to 48 hours after transfection, G2A-transfected cells, but not mock (vector)-transfected cells, began to display significant cytoplasmic shrinkage, cell rounding, and membrane blebbing (Fig. 4A) . Expression of G2A also caused a decrease in mitochondrial membrane potential as determined by negative staining with TMRE. TMRE is a cationic, lipophilic dye that is dissipated when there is a large reduction in mitochondrial membrane potential, an event that occurs in most cases of both receptor-mediated and stressinduced apoptosis (21) . As a result, apoptotic cells show much less staining with this rhodamine-based dye, while live cells stain positively with TMRE ( Fig. 4B and also Fig. 5A ).
Hoechst 33342 was used to stain condensed nuclear chromatin in apoptotic cells. As shown in including NIH 3T3, COS-7, Saos2, and U20S, were also susceptible to G2A-mediated apoptosis (data not shown), suggesting that this effect is not restricted to one cell type. In order to confirm that the apoptotic cells were those that expressed G2A, we used a G2A-green fluorescent protein (GFP) fusion construct (1) for transfecting HeLa cells. We found that the cells that underwent apoptosis were indeed GFP-positive (data not shown). In control experiments, expression of the empty vector, pEGFP, did not increase the number of apoptotic cells. The two caspase inhibitors, compared to Bcl-2, had a greater effect in rescuing cells from G2A-mediated apoptosis, as implicated by the fold change in apoptosis (see figure 5B) . The antiapoptotic protein Bcl-2 decreases the basal level of apoptosis, but G2A co-transfection with Bcl-2 still results in more than a 2-fold increase in apoptosis over the control (Bcl-2 alone). On the other hand, G2A co-transfection with CrmA (or zvad treatment) results in only a 1.2-1.3-fold increase in apoptosis over control (CrmA or zvad alone), suggesting that caspase inhibitors have a greater effect in protecting cells from G2A-mediated apoptosis than Bcl-2.
G2A-mediated apoptosis involves multiple G proteins.
Given that other GPCRs that couple to Gα13 and Gαq (e.g. PAR-1 and the GPCR encoded by ORF74 of Kaposi's sarcomaassociated herpesvirus) (11, 16, 22) do not cause apoptosis, we speculated that G2A may activate a distinct combination of G proteins that leads to apoptosis. To ascertain which Gα proteins G2A utilizes to induce apoptosis, we first sought to investigate the role of LPCstimulated cAMP elevation on G2A-mediated apoptosis. LPC stimulation enhanced G2A-mediated apoptosis in a dose-dependent manner that correlated with its effect on cAMP elevation (Fig. 6A), i. e., the concentration of LPC that induced maximal apoptosis (0.5 µM) coincided with the dose that stimulated peak elevation of cAMP (Fig. 3B) . This result indicates that Gαs activation, either alone or in combination with other signals, may be critical in G2A-mediated apoptosis.
Given the ability of LPC to induce apoptosis in G2A-expressing HeLa cells, we next examined the effect of LPC stimulation in cells which normally express endogenous G2A receptor, i.e., lymphocytes. By RT-PCR, we confirmed expression of G2A in primary T lymphocytes isolated from the blood of healthy human donors (Fig. 6B) . Interestingly, we found that the transcript for GPR4, the low affinity receptor for LPC, is barely detectable in primary T lymphocytes. As depicted in Figure 6 , T lymphocytes that were stimulated with nanomolar concentrations of LPC (0.01 or 0.5 µM) showed a dramatic increase in apoptosis as shown by an increase in the number of cells which had reduced TMRE staining (from 27% to 87%).
Furthermore, this increase in apoptosis correlated with a dose-dependent increase in cAMP elevation (Fig. 6C) .
A number of G proteins, including Gα13, Gαq, and Gαs, have been implicated in GPCRmediated apoptosis (23) (24) (25) (26) . We therefore examined the ability of constitutively activated Gα subunits (with Q→L mutation) to induce apoptosis in our system. The results indicate that expression of GαsQL alone did not induce apoptosis in HeLa cells, whereas expression of either Gα13QL or GαqQL induced apoptosis to a small extent (Fig. 7A) . Interestingly, when both Gα13QL and GαsQL were transfected together, a synergism was achieved which mimics the level of apoptosis of that seen in G2A-transfected cells. In contrast, when GαqQL was expressed in combination with GαsQL or Gα13QL, there was no additive or synergistic effect.
All Gα(QL) constructs have been tested for constitutive activity by either second messenger accumulation assays (InsP for GαqQL and cAMP for GαsQL), or by the NF-κB-and SREluciferase reporter assays (for Gα13QL) (data not shown).
To determine if G2A utilizes Gαs and/or Gα13-mediated pathways to mediate apoptosis, we used various inhibitors and RGS constructs to attempt pathway-specific rescue from G2A-by guest on August 17, 2017 http://www.jbc.org/ Downloaded from induced apoptosis. Both the p115RGS construct and the adenylate cyclase inhibitor DDA partially rescued cells from G2A-mediated apoptosis (Fig. 7B) . In comparison, GRK2RGS was much less effective. When DDA and p115RGS were used simultaneously, G2A-induced apoptosis was inhibited to a greater extent. The various constructs and inhibitors did not have a great effect on the basal level of vector-transfected cells that show reduced TMRE staining (data not shown). These results indicate that Gαs and Gα13 play critical roles in G2A-mediated apoptosis.
Discussion
Our results reveal primarily two novel findings. The first involves the differential activation of G proteins by G2A depending on whether or not it is stimulated by LPC. According to our second messenger accumulation measurements and NF-κB reporter data, G2A may ligand-independently couple to a unique combination of G proteins: Gαq, Gαs, and Gα13 (Gαi involvement appears to be minimal at most). LPC stimulation of G2A-transfected cells enhances activation of Gαs resulting in a greater elevation of cAMP (Fig. 3A,B ) while failing to alter inositol phosphate levels (Fig. 1A) . On the other hand, previous reports describe PTXsensitive LPC signaling through G2A causing ERK phosphorylation and an increase in intracellular [Ca 2+ ], implying the involvement of Gαi (10) . While this discrepancy may be due to differences in the cell lines utilized, it is also noted that LPC stimulation of Gαs was not specifically investigated in that study. Our finding that LPC induces G2A-mediated Gαs activation is consistent with a previous report demonstrating the ability of LPC to stimulate G protein-dependent elevation of cAMP in platelets (27) , indicating the importance of investigating the LPC effects in cells that endogenously express G2A.
The second new finding is that expression of G2A causes caspase-dependent apoptosis via the activation of a specific combination of G proteins and that LPC stimulation of G2A enhances apoptosis. The fact that G2A expression results in apoptosis is consistent with the implications derived from G2A-deficient mice which develop autoimmune disease, as well as the growth inhibitory properties displayed by G2A-expressing Rat-1 fibroblasts and mouse bone marrow cells (1, 2) . Recent evidence also shows that G2A-deficient mice have a faster disease progression in BCR-ABL-driven leukemia than wild type mice, thus supporting the notion that G2A plays a negative role in regulating peripheral lymphocyte numbers by causing apoptosis (28). Furthermore, we demonstrate here that the viral serpin caspase-8 inhibitor, CrmA (29), is just as effective in rescuing cells from G2A-mediated apoptosis as the pan-caspase inhibitor zvad-fmk, while Bcl-2 did not have as great an effect (Fig. 5) . Since caspase-8 is thought to be a target of receptor-mediated apoptotic pathways such as those involving TNFα/FasL, the ability of CrmA but not Bcl-2 to inhibit G2A-mediated apoptosis suggests that G2A may share more similarities to known receptor-mediated pathways than it does to stress-induced pathways.
Indeed, there exists an autoimmune lymphoproliferative syndrome similar to SLE which causes defective lymphocyte apoptosis due to mutations of the Fas receptor (30) . Whether G2A recruits any of the direct upstream components of the death receptor pathways such as FADD, TRADD, or RIP, or whether G2A enhances TNF/Fas-mediated apoptosis may be an interesting direction to pursue in future studies.
We have attempted to identify the proximal signaling mechanisms for G2A-mediated apoptosis. Our results confirm studies conducted by two separate groups (6,9) describing the ability of G2A to couple functionally and ligand-independently to Gα13. As of late, there has been a revision in the conventional model of ligand-receptor interactions to incorporate the finding that several native GPCRs (not virally encoded), such as certain serotonin receptors (31) , exhibit a significant level of basal activity in the absence of ligand. Virally encoded GPCRs (e.g. US28 and KSHV-GPCR) have also been shown to activate multiple G proteins ligandindependently, the result being cellular transformation rather than apoptosis (14, 22) . In fact, Gα13 in the same cell line tested in this report (16) . The dramatic difference in phenotype (transformation vs. apoptosis) may be due to the combination of G proteins activated specifically by G2A. Activation of Gα13, in combination with Gαs-mediated pathways may be required, in our cell system, to mediate apoptosis instead of transformation. In fact, in an additional experiment, we have seen that co-expression of KSHV-GPCR with constitutively active GαsQL successfully mimics the level of apoptosis seen with G2A, while expression of either alone has no effect on apoptosis (unpublished results). Therefore, it appears that a complex web of events in which certain G protein pathways work in the context of other activated pathways must occur to achieve the ultimate result, in this case, apoptosis.
An important issue remains, concerning the ability of T lymphocytes to express G2A and G2A has been implicated in the control of cellular proliferation and negative regulation of self-recognizing lymphocytes. Its ligand, LPC, has been implied in a variety of cellular processes such as chemotaxis of monocytes and T cells and growth inhibition of smooth muscle cells and endothelial cells (32, 33) , although these phenomena have yet to be correlated with a specific cell surface receptor. As previous studies have described other lysophospholipids (e.g.
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